Medical Marijuana: What Psychiatrists Need to Know

TORONTO — Medical marijuana is currently legal in 23 states and the District of Columbia. On a regular basis, studies are released supporting the use of cannabis for the use in the treatment of psychiatric disorders, including post-traumatic stress disorder (PTSD).

Despite the growing calls to expand the use of marijuana for a host of medical conditions, psychiatrists should be hesitant as much of the data out there is inconclusive and marijuana use, even for supposed medicinal purposes, can lead to addiction in some cases, according to Kevin P. Hill, MD, a psychiatrist at McLean Hospital in Belmont, Mass. and an assistant professor at Harvard Medical School.

“It's an important time to understand what the science is,” Hill told Psychiatry Advisor prior to a presentation on what psychiatrists need to know about medical marijuana at the American Psychiatric Association Annual Meeting. “There's a gap between what the science...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.